However, its important to note that BPC-157 should not be used as a substitute for regular exercise or proper nutrition
You should stop using Wegovy 2 months before you plan to become pregnant are breastfeeding or plan to breastfeed
As always, treatment decisions should be individualized, considering kidney function, comorbidities, adverse-event profile, costs and reimbursement, and patient preferences
Semaglutide (Wegovy) FDA-approved for: Chronic weight management Treatment of Metabolic dysfunction-Associated Steatohepatitis (MASH) approved August 2025 FDA-indicated for: Reducing risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease who are obese or overweight Weekly injection Clinical trials show an average weight loss of 1215% of body weight
In clinical trials, most participants who experienced even moderate GI symptoms were able to continue with appropriate management
If antiemetics or prokinetics are necessary, stabilize those first